DEA Schedule CII

Strength

1.875; 1.875; 1.875; 1.875 mg/1; mg/1; mg/1; mg/1

Manufacturer

SpecGx LLC

NDC

00406888401

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Last Updated

4/22/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA040440

On Market Since

10/7/2003

Pharmacological Classes

Central Nervous System Stimulant
Central Nervous System Stimulant
Central Nervous System Stimulant
Central Nervous System Stimulant
Central Nervous System Stimulation
Central Nervous System Stimulation
Central Nervous System Stimulation
Central Nervous System Stimulation

Price History

1W

0.0%

1M

-5.2%

3M

-6.3%

6M

+0.9%

1Y

-23.1%

3Y

-44.6%

5Y

-64.5%

All

-52.2%

Generic Alternatives

No alternatives available

No alternatives found with the same active ingredient, strength, and dosage form.